Compare companies
Biocon Limited | Cipla Limited | Torrent Pharmaceuticals Limited | ||||
---|---|---|---|---|---|---|
Capitalization | ||||||
Price | 322.9 | 1461.6 | 3058.45 | |||
Price priv. | ||||||
Number of shares, million | 1196.8 | 807.37 | 338.45 | |||
Capitalization, billion | 299.31 | 846.5 | 656.92 | |||
EBITDA, billion | 24.29 | 53.2 | 28.87 | |||
EV, billion | 446.74 | 820.34 | 897.78 | |||
Profit and loss report | ||||||
Net profit, billion | 10.23 | 41.22 | 16.56 | |||
Revenue, billion | 141.96 | 254.47 | 105.62 | |||
EPS | 8.54 | 51.05 | 48.94 | |||
Balance | ||||||
Assets, billion | 560.71 | 327.18 | 150.61 | |||
Debt, billion | 157.3 | 3.85 | 39.37 | |||
Balance cost, billion | 197.84 | 267.06 | 68.56 | |||
Cash, billion | 12.33 | 6.4 | 8.35 | |||
Coefficients | ||||||
Dividend yield, % | 0.4195 | 0.5498 | 1.48 | |||
Dividend | 0.5 | 13 | 32 | |||
Dividend yield priv., % | 0 | 0 | 0 | |||
Dividend priv. | 0 | 0 | 0 | |||
Dividends/profit, % | 19.85 | 16.65 | 61.28 | |||
P/S | 2.13 | 4.7 | 8.21 | |||
P/BV | 1.19 | 4.46 | 12.64 | |||
P/E | 29.51 | 29.01 | 52.33 | |||
Ev/Ebitda | 16.97 | 17.88 | 19.65 | |||
Debt/Ebitda | 6.48 | 0.0724 | 1.36 | |||
Efficiency | ||||||
ROE | 5.43 | 16.45 | 25.38 | |||
ROA | 1.89 | 13.26 | 11.02 | |||
ROIC | 1.86 | 14.66 | 19.66 | |||
Ebitda margin | 17.11 | 20.91 | 27.33 | |||
Net margin | 7.2 | 16.2 | 15.68 | |||
Momentum | ||||||
1 week, price changes | -3.16 % | +0.2022 % | -0.4443 % | |||
1 month, price changes | -9.4 % | +0.8139 % | -0.1502 % | |||
3 months, price changes | -8.45 % | +0.9846 % | -8.64 % | |||
6 months, price changes | -17.36 % | -11.93 % | -11.41 % | |||
1 year, price changes | +20.96 % | -2.37 % | +13.41 % | |||
3 years, price changes | -3.03 % | +48.12 % | +10.48 % | |||
5 years, price changes | +9.64 % | +227.05 % | +58.44 % | |||
10 years, price changes |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription